Nov 12, 2020 / 09:15PM GMT
Andrew E. Singer - Credit Suisse Group AG - MD of Healthcare Investment Banking Division
Hello, and good afternoon. It's Andy Singer with Credit Suisse. I'm very happy to introduce to you the management team of Chimerix, the team that I've known for many years. They have a very successful track record in business operations, drug development and strategy with a very successful exit at their prior company, Endocyte, which as you, I'm sure, aware was sold to Novartis and a very successful exit, and now the team is at Chimerix. And here today to tell you about their programs is Mike Sherman, who's the Chief Executive Officer; Mike Andriole, who's the CBO and CFO; and then Allen Melemed, who's the Chief Medical Officer.
So with that, I'll turn it over to Mike.
Michael A. Sherman - Chimerix, Inc. - CEO, President & Director
Thanks, Andy. And let me bring my presentation up and make sure we're in sharing mode here. Great. Andy, thanks for having us. Always great to present at this conference, and it's particularly fun to present here when we've got some
Chimerix Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 13, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers